TGM2 and celiac disease: Small molecule TG2 inhibitors have been shown to hold therapeutic potential for the treatment of these diseases, with ZED1227 advancing to clinical trials for the treatment of celiac disease.11 Thus, the development of novel therapeutic agents that target TG2 function is considered a crucial avenue of research.